Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
516.00
Ask:
520.00
Spread: 4.00 (0.775%)
Market Cap: £860.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Key management appointment

3 Aug 2010 08:00

RNS Number : 4035Q
Oakley Capital Investments Limited
03 August 2010
 



3 August 2010

Oakley Capital Investments Limited

Key management appointment

Del Huse joins Oakley Capital Private Equity Del Huse has joined Oakley Capital Limited ("Oakley Capital"), Investment Adviser to Oakley Capital Private Equity LP, as a Managing Director. Del will principally focus on new deal origination for the business in the UK and European mid-market.

Del joins from Endless LLP, the UK-based private equity house, where he led the London operation from February 2008 to May 2010, specialising in the provision of financial investment and 'turnaround' expertise to businesses facing challenges or finding themselves in special situations. Prior to Endless, Del was an M&A Partner at Zolfo Cooper for 5 years, having initially trained as a Chartered Accountant at Arthur Andersen.  

Del said,

 

"The opportunity to join Oakley Capital was compelling. Working in a private equity group with a reputation for real entrepreneurial leadership and for doing deals that others would simply find too challenging provides real points of difference in a crowded private equity market."

 

Peter Dubens, added,

 

"I am delighted that Del is joining the team at Oakley Capital. The Limited Partnership's focus continues to be on the turnaround of underperforming assets in consolidating or growth industries or within sectors which are subject to structural change, and I believe that Del brings with him valuable experience of these types of deals." 

-ends-

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Peter Dubens (Managing Partner)

Financial Dynamics

+44 20 7831 3113

Juliet Clarke / Erwan Gouraud

 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Steven Tredget

About Oakley Capital Investments Limited

 

The Company was established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity LP. The primary objective of the Oakley Capital Private Equity LP is to invest in a diverse portfolio of private mid-market UK and European businesses, aiming to provide investors with significant long-term capital appreciation.

 

The investment strategy of the Oakley Capital Private Equity LP is to focus on companies with the scope for performance improvement operating within industries with growth or consolidation potential. In addition, the Oakley Capital Private Equity LP seeks to invest in companies with the potential to achieve scale, thereby commanding a premium on exit.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXLLLBBVFFBBF
Date   Source Headline
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing
15th Mar 20237:15 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
9th Mar 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
27th Feb 20237:00 amRNSNotice of Results and Investor Presentation
25th Jan 20237:00 amRNSTrading update for the year ended 31 December 2022
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20232:15 pmEQSHardman & Co Q&A on Oakley Capital Investments Ltd (OCI): High-growth drivers in 2023
15th Dec 20227:00 amRNSOCI commits EUR 30m to Oakley PROfounders III
29th Nov 20227:30 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): Evolution of the high-growth drivers in 2023
10th Nov 20224:17 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.